Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer

Journal of Interferon and Cytokine Research

Volumn 33, Issue 9, 2013, Pages 467-484

  Medvedev, Andrei E ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6;

ADAPTIVE IMMUNITY; ALLERGY; CARCINOGENESIS; ENVIRONMENTAL FACTOR; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TLR GENE;

COMMUNICABLE DISEASES; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; INFLAMMATION; MUTATION; NEOPLASMS; POLYMORPHISM, GENETIC; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84883734982     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0140     Document Type: Review

References (259)

1. Abreu MT. 2010. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10:131-144.
2. Adjers K, Karjalainen J, Pessi T, Eklund C, Hurme M. 2005. Epistatic effect of TLR4 and IL4 genes on the risk of asthma in females. Int Arch Allergy Immunol 138:251-256.
3. Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF. 2002. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186: 1522-1525.
4. Ahmad-Nejad P, Denz C, Zimmer W, Wacker J, Bugert P, Weiss C, Quintel M, Neumaier M. 2011. The presence of functionally relevant toll-like receptor polymorphisms does not significantly correlate with development or outcome of sepsis. Genet Test Mol Biomarkers 15:645-651.
5. Akashi-Takamura S, Miyake K. 2008. TLR accessory molecules. Curr Opin Immunol 20:420-425.
6. Al-Qahtani A, Al-Ahdal M, Abdo A, Sanai F, Al-Anazi M, Khalaf N, Viswan NA, Al-Ashgar H, Al-Humaidan H, Al-Suwayeh R, Hussain Z, Alarifi S, Al-Okail M, Almajhdi FN. 2012. Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients. J Med Virol 84:1353-1359.
7. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NFkB by Toll-like receptor 3. Nature 413:732-738.
8. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187-191.
9. Askar E, Bregadze R, Mertens J, Schweyer S, Rosenberger A, Ramadori G, Mihm S. 2009. TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C. J Med Virol 81:1204-1211.
10. Awomoyi AA, Rallabhandi P, Pollin TI, Lorenz E, Sztein MB, Boukhvalova MS, Hemming VG, Blanco JC, Vogel SN. 2007. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol 179:3171-3177.
11. Bagashev A, Fitzgerald MC, Larosa DF, Rose PP, Cherry S, Johnson AC, Sullivan KE. 2010. Leucine-rich repeat (in Flightless I) interacting protein-1 regulates a rapid type I interferon response. J Interferon Cytokine Res 30:843-852.
12. Balistreri CR, Candore G, Lio D, Colonna-Romano G, Di Lorenzo G, Mansueto P, Rini G, Mansueto S, Cillari E, Franceschi C, Caruso C. 2005. Role of TLR4 receptor polymorphisms in Boutonneuse fever. Int J Immunopathol Pharmacol 18: 655-660.
13. Balkwill F, Mantovani A. 2001. Inflammation and cancer: back to Virchow? Lancet 357:539-545.
14. Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW. 2004. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 41:808-813.
15. Barber RC, Chang LY, Arnoldo BD, Purdue GF, Hunt JL, Horton JW, Aragaki CC. 2006. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin Med Res 4:250-255.
16. Barreiro LB, Ben-Ali M, Quach H, Laval G, Patin E, Pickrell JK, Bouchier C, Tichit M, Neyrolles O, Gicquel B, Kidd JR, Kidd KK, Alca?̈s A, Ragimbeau J, Pellegrini S, Abel L, Casanova JL, Quintana-Murci L. 2009. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet 5:e1000562.
17. Belhocine K, Monack DM. 2012. Francisella infection triggers activation of the AIM2 inflammasome in murine dendritic cells. Cell Microbiol 14:71-80.
18. Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. 2004. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 11:625-626.
19. Bergmann C, Bachmann HS, Bankfalvi A, Lotfi R, Pü tter C, Wild CA, Schuler PJ, Greve J, Hoffmann TK, Lang S, Scherag A, Lehnerdt GF. 2011. Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas. J Transl Med 9:139
20. Beutler B. 2009. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 227:248-263.
21. Bhide MR, Mucha R, Mikula I Jr., Kisova L, Skrabana R, Novak M, Mikula I Sr. 2009. Novel mutations in TLR genes cause hyporesponsiveness to Mycobacterium avium subsp. paratuberculosis infection. BMC Genet 10:21.
22. Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP, Wagner H, Kirschning CJ, Ter Meulen V, Schneider-Schaulies S. 2002. Hemagglutinin protein of wildtype measles virus activates toll-like receptor 2 signaling. J Virol 76:8729-8736.
23. Biswas D, Gupta SK, Sindhwani G, Patras A. 2009. TLR2 polymorphisms, Arg753Gln and Arg677Trp, are not associated with increased burden of tuberculosis in Indian patients. BMC Res Notes 2:162.
24. Bjørnvold M, Munthe-Kaas MC, Egeland T, Joner G, Dahl-Jørgensen K, Njølstad PR, Akselsen HE, Gervin K, Carlsen KC, Carlsen KH, Undlien DE. 2009. A TLR2 polymorphism is associated with type 1 diabetes and allergic asthma. Genes Immun 10:181-187.
25. Bochud PY, Hawn TR, Aderem A. 2003. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 170:3451-3454.
26. Bochud PY, Hersberger M, Taffé P, Bochud M, Stein CM, Rodrigues SD, Calandra T, Francioli P, Telenti A, Speck RF, Aderem A; Swiss HIV Cohort Study. 2007. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 21:441-446.
27. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, Kim YM. 2007 The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 177:265-275.
28. Bulut Y, Faure E, Thomas L, Equilis O, Arditi M. 2001. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 167:987-994.
29. Bulut Y, Faure E, Thomas L, Karahashi H, Michelsen KS, Equils O, Morrison SG, Morrison RP, Arditi M. 2002. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 168:1435-1440.
30. Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, Tschopp J. 2003. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med 197:263-268.
31. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. 2003. Regulatory T cells selectively express tolllike receptors and are activated by lipopolysaccharide. J Exp Med 197:403-411.
32. Carpenter S, O'Neill LA. 2009. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem J 422:1-10.
33. Cheng H, Addona T, Keshishian H, Dahlstrand E, Lu C, Dorsch M, Li Z, Wang A, Ocain TD, Li P, Parsons TF, Jaffee B, Xu Y. 2007. Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop. Biochem Biophys Res Commun 352:609-616.
34. Cho HJ, Kim SH, Kim JH, Choi H, Son JK, Hur GY, Park HS. 2011. Effect of Toll-like receptor 4 gene polymorphisms on work-related respiratory symptoms and sensitization to wheat flour in bakery workers. Ann Allergy Asthma Immunol 107:57-64.
35. Citores MJ, Bañ os I, Noblejas A, Rosado S, Castejon R, Cuervas-Mons V. 2011. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis. Transplant Proc 43:2224-2226.
36. Conze DB, Wu CJ, Thomas JA, Landstrom A, Ashwell JD. 2008. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor-and toll-like receptor-mediated NFkappaB activation. Mol Cell Biol 28:3538-3547.
37. Corr SC, O'Neill LA. 2009. Genetic variation in Toll-like receptor signalling and the risk of inflammatory and immune diseases. J Innate Immun 1:350-357.
38. Dalgic N, Tekin D, Kayaalti Z, Soylemezoglu T, Cakir E, Kilic B, Kutlubay B, Sancar M, Odabasi M. 2011. Arg753Gln polymorphism of the human Toll-like receptor 2 gene from infection to disease in pediatric tuberculosis. Hum Immunol 72:440-445.
39. Davoodi H, Hashemi SR, Seow HF. 2012. Increased NFk-B activity in HCT116 colorectal cancer cell line harboring TLR4 Asp299Gly variant. Iran J Allergy Asthma Immunol 11:121-132.
40. De Staercke C, Lally C, Austin H,Winston C, Dowling N,Williams B, Hooper WC. 2007. The lack of association between four point mutations in the promoter region of the toll-like 4 receptor gene and myocardial infarction. Thromb Res 119:105-110.
41. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ. 2000. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361.
42. DiDonato JA, Mercurio F, Karin M. 2012. NF-kB and the link between inflammation and cancer. Immunol Rev 246:379-400.
43. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-1531.
44. Dong W, Liu Y, Peng J, Chen L, Zou T, Xiao H, Liu Z, Li W, Bu Y, Qi Y. 2006. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4. J Biol Chem 281:26029-26040.
45. Doyle SL, O'Neill LA. 2006. Toll-like receptors: from the discovery of NF-kB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72:1102-1113.
46. Drage MG, Pecora ND, Hise AG, Febbraio M, Silverstein RL, Golenbock DT, Boom WH, Harding CV. 2009. TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. Cell Immunol 258:29-37.
47. Dunstan SJ, Hawn TR, Hue NT, Parry CP, Ho VA, Vinh H, Diep TS, House D, Wain J, Aderem A, Hien TT, Farrar JJ. 2005. Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J Infect Dis 191:1068-1071.
48. Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, Braun-Fahrländer C, Nowak D, Martinez FD; ALEX Study Team. 2004. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 113: 482-488.
49. Edfeldt K, Bennet AM, Eriksson P, Frostegard J, Wiman B, Hamsten A, Hansson GK, de Faire U, Yan ZQ. 2004. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 25:1447-1453.
50. El-Omar EM, Ng MT, Hold GL. 2008. Polymorphisms in Tolllike receptor genes and risk of cancer. Oncogene 27:244-252.
51. Emingil G, Berdeli A, Baylas H, Saygan BH, Gü rkan A, Kö se T, Atilla G. 2007. Toll-like receptor 2 and 4 gene polymorphisms in generalized aggressive periodontitis. J Periodontol 78:1968-1977.
52. Etokebe GE, Skjeldal F, Nilsen N, Rodionov D, Knezevic J, Bulat-Kardum L, Espevik T, Bakke O, Dembic Z. 2010. Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele. Scand J Immunol 71:369-381.
53. Everett B, Cameron B, Li H, Vollmer-Conna U, Davenport T, Hickie I, Wakefield D, Vernon S, Reeves WC, Lloyd AR. 2007. Polymorphisms in Toll-like receptors-2 and-4 are not associated with disease manifestations in acute Q fever. Genes Immun 8:699-702.
54. Fageras Bö ttcher M, Hmani-Aifa M, Lindström A, Jenmalm MC, Mai XM, Nilsson L, Zdolsek HA, Bjö rkstén B, Sö derkvist P, Vaarala O. 2004. A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J Allergy Clin Immunol 114:561-567.
55. Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano L, Kang S, Wu J, Datta P, McCormick M, Huang L, McDermott E, Eisenlohr L, Landel CP, Alnemri ES. 2010. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 11:385-393.
56. Ferwerda B, Kibiki GS, Netea MG, Dolmans WM, van der Ven AJ. 2007 The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS 21:1375-1377.
57. Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, Van der Meer JW, Netea MG. 2008. Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 14: 346-352.
58. Feterowski C, Emmanuilidis K, Miethke T, Gerauer K, Rump M, Ulm K, Holzmann B, Weighardt H. 2003. Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 109:426-431.
59. Figueroa L, Xiong Y, Song C, Piao W, Vogel SN, Medvedev AE. 2012. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF. J Immunol 188:4506-4515.
60. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003a. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491-496.
61. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, Monks B, Pitha PM, Golenbock DT. 2003b. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 198:1043-1055.
62. Flannery S, Bowie AG. 2010. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. Biochem Pharmacol 80 (12):1981-1991.
63. Flo TH, Ryan L, Latz E, Takeuchi O, Monks BG, Lien E, Halaas ∅, Akira S, Skjak-Braek G, Golenbock DT, Espevik T. 2002. Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J Biol Chem 277:35489-35495.
64. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Devière J, Rutgeerts P. 2004. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53:987-992.
65. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 176:1665-1671.
66. Galli E, Ciucci A, Cersosimo S, Pagnini C, Avitabile S, Mancino G, Delle Fave G, Corleto VD. 2010. Eczema and food allergy in an Italian pediatric cohort: no association with TLR-2 and TLR-4 polymorphism. Int J Immunopathol Pharmacol 23:671-675.
67. Garantziotis S, Hollingsworth JW, Zaas AK, Schwartz DA. 2008. The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 59:343-345.
68. Gast A, Bermejo JL, Claus R, Brandt A, Weires M, Weber A, Plass C, Sucker A, Hemminki K, Schadendorf D, Kumar R. 2011. Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival. PLoS One 6:e24370.
69. Gay NJ, Gangloff M, O'Neill LA. 2011. What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol 32:104-109.
70. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. 2001. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 167:1882-1885.
71. Guarner-Argente C, Sanchez E, Vidal S, Roman E, Concepcion M, Poca M, Sanchez D, Juarez C, Soriano G, Guarner C. 2010. Toll-like receptor 4 D299G polymorphism and the incidence of infections in cirrhotic patients Aliment Pharmacol Ther 31:1192-1199.
72. Guggemoos S, Hangel D, Hamm S, Heit A, Bauer S, Adler H. 2008. TLR9 contributes to antiviral immunity during gammaherpesvirus infection. J Immunol 180:438-443.
73. Hawke NA, Yoder JA, Litman GW. 1999. Expanding our understanding of immunoglobulin, T-cell antigen receptor, and novel immune-type receptor genes: a subset of the immunoglobulin gene superfamily. Immunogenetics 50:124-133.
74. Hawn TR, Scholes D, Li SS, Wang H, Yang Y, Roberts PL, Stapleton AE, Janer M, Aderem A, Stamm WE, Zhao LP, Hooton TM. 2009a. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One 4:e5990.
75. Hawn TR, Scholes D, Wang H, Li SS, Stapleton AE, Janer M, Aderem A, Stamm WE, Zhao LP, Hooton TM. 2009b. Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS One 4:e8300.
76. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ, Skerrett SJ, Beutler B, Schroeder L, Nachman A, Ozinsky A, Smith KD, Aderem A. 2003. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 198:1563-1572.
77. Hayes MW, Carrion R Jr., Nunneley J, Medvedev AE, Salvato MS, Lukashevich IS. 2012. Pathogenic Old World Arenaviruses Inhibit TLR2/Mal-Dependent Proinflammatory Cytokines In Vitro. J Virol 86:7216-7226.
78. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526-1529.
79. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
80. Henckaerts L, Nielsen KR, Steffensen R, Van Steen K, Mathieu C, Giulietti A, Wouters PJ, Milants I, Vanhorebeek I, Langouche L, Vermeire S, Rutgeerts P, Thiel S, Wilmer A, Hansen TK, Van den Berghe G. 2009. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med 37:192-201, e1-3.
81. Hidmark A, von Saint Paul A, Dalpke AH. 2012. Cutting edge: TLR13 is a receptor for bacterial RNA. J Immunol 189:2717-2721.
82. Hirano M, Das S, Guo P, Cooper MD. 2011. The evolution of adaptive immunity in vertebrates. Adv Immunol 109:125-157.
83. Hoebe K, Beutler B. 2006. TRAF3: a new component of the TLRsignaling apparatus. Trends Mol Med 12:187-189.
84. Holgate ST. 2012. Innate and adaptive immune responses in asthma. Nat Med 18:673-678.
85. Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, Ohba Y, Takaoka A, Yeh WC, Taniguchi T. 2004. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 101:15416-15421.
86. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdö rfer B, Giese T, Endres S, Hartmann G. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531-4537.
87. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749-3752.
88. Hsieh YY, Wan L, Chang CC, Tsai CH, Tsai FJ. 2009. STAT2*C related genotypes and allele but not TLR4 and CD40 gene polymorphisms are associated with higher susceptibility for asthma. Int J Biol Sci 5:74-81.
89. Huang YS, Misior A, Li LW. 2005. Novel role and regulation of the interleukin-1 receptor associated kinase (IRAK) family proteins. Cell Mol Immunol 2:36-39.
90. Hume GE, Fowler EV, Doecke J, Simms LA, Huang N, Palmieri O, Griffiths LR, Florin TH, Annese V, Radford-Smith GL. 2008. Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population. Inflamm Bowel Dis 14:585-590.
91. Husebye H, Aune MH, Stenvik J, Samstad E, Skjeldal F, Halaas O, Nilsen NJ, Stenmark H, Latz E, Lien E, Mollnes TE, Bakke O, Espevik T. 2010. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 33:583-596.
92. Hussein YM, Awad HA, Shalaby SM, Ali AS, Alzahrani SS. 2012. Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and susceptibility to asthma and allergic rhinitis: a case-control analysis. Cell Immunol 274:34-38.
93. Ishizaki Y, Takemoto M, Kira R, Kusuhara K, Torisu H, Sakai Y, Sanefuji M, Yukaya N, Hara T. 2008. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis. J Neurovirol 14:486-491.
94. Janeway CA. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54:1-13.
95. Jessen KM, Lindboe SB, Petersen AL, Eugen-Olsen J, Benfield T. 2007. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis. BMC Infect Dis 7:108.
96. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C, Keck S, Galanos C, Freudenberg M, Beutler B. 2005. CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6:565-570.
97. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO. 2007. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071-1082.
98. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E, Hamann L, Schumann RR, Tapping RI. 2007. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 178:7520-7524.
99. Jones JW, Kayagaki N, Broz P, Henry T, Newton K, O'Rourke K, Chan S, Dong J, Qu Y, Roose-Girma M, Dixit VM, Monack DM. 2010. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci USA 107:9771-9776.
100. Junjie X, Songyao J, Minmin S, Yanyan S, Baiyong S, Xiaxing D, Jiabin J, Xi Z, Hao C. 2012. The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility. BMC Cancer 12:57-65.
101. Kagan JC, Medzhitov R. 2006. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125:943-955.
102. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9:361-368.
103. Kang SH, Abdel-Massih RC, Brown RA, Dierkhising RA, Kremers WK, Razonable RR. 2012. Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation. J Infect Dis 205:639-646.
104. Kang TJ, Chae GT. 2001. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 31:53-58.
105. Kang TJ, Lee SB, Chae GT. 2002. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 20:56-62.
106. Kawagoe T, Sato S, Matsushita K, Kato H, Matsui K, Kumagai Y, Saitoh T, Kawai T, Takeuchi O, Akira S. 2008. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat Immunol 9:684-691.
107. Kawai T, Akira S. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637-650.
108. Keating SE, Maloney GM, Moran EM, Bowie AG. 2007. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination. J Biol Chem 282:33435-33443.
109. Kerkhof M, Postma DS, Brunekreef B, Reijmerink NE, Wijga AH, de Jongste JC, Gehring U, Koppelman GH. 2010. Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma. Thorax 65:690-697.
110. Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B. 2011. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. CellHostMicrobe 9:363-375.
111. Kesh S, Mensah NY, Peterlongo P, Jaffe D, Hsu K, Van Den Brink M, O'reilly R, Pamer E, Satagopan J, Papanicolaou GA. 2005. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci 1062:95-103.
112. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA. 2002a. Toll-like receptor 4 polymorphisms and atherogenesis N Engl J Med 347: 185-192.
113. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA. 2002b. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-192.
114. Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR. 2007. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis 44:1315-1320.
115. Kim do Y, Choi JW, Chang HY, Kim SU, Park H, Paik YH, Kim JK, Ahn SH, Park JY, Chung SI, Lee KS, Han KH, Chon CY. 2010. Toll-like receptor polymorphisms are not associated with liver cirrhosis in hepatitis B virus infected Korean patients. Hepatogastroenterology 57:1351-1355.
116. Kono H, Rock KL. 2008. How dying cells alert the immune system to danger Nat Rev Immunol 8:279-289.
117. Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, Orihuela MM, Akira S, Yokoyama WM, Colonna M. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21:107-119.
118. Kurowski M, Majkowska-Wojciechowska B, Wardzyń ska A, Kowalski ML. 2011. Associations of allergic sensitization and clinical phenotypes with innate immune response genes polymorphisms are modified by house dust mite allergen exposure. Arch Med Sci 7:1029-1036.
119. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398-401.
120. Lachheb J, Dhifallah IB, Chelbi H, Hamzaoui K, Hamzaoui A. 2008. Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children. Tissue Antigens 71:417-425.
121. Latha M, Vaidya S, Movva S, Chava S, Govindan S, Govatati S, Banoori M, Hasan Q, Kodati VL. 2011. Molecular pathogenesis of endometriosis; Toll-like receptor-4 A896G (D299G) polymorphism: a novel explanation. Genet Test Mol Biomarkers 15:181-184.
122. Lee HK, Dunzendorfer S, Soldau K, Tobias PS. 2006. Doublestranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24:153-163
123. Lee SO, Brown RA, Kang SH, Abdel-Massih RC, Razonable RR. 2011. Toll-like receptor 2 polymorphism and Gram-positive bacterial infections after liver transplantation. Liver Transpl 17:1081-1088.
124. Lee YH, Lee HS, Choi SJ, Ji JD, Song GG. 2012. Associations between TLR polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. Clin Exp Rheumatol 30:262-265.
125. Li S, Strelow A, Fontana EJ, Wesche H. 2002. IRAK-4: a novel member of the IRAK family with the properties of an IRAKkinase. Proc Natl Acad Sci USA 99:5567-5572.
126. Li X. 2008. IRAK4 in TLR/IL-1R signaling: possible clinical applications. Eur J Immunol 38:614-618.
127. Liadaki K, Petinaki E, Skoulakis C, Tsirevelou P, Klapsa D, Germenis AE, Speletas, M. 2011. Toll-like receptor 4 gene (TLR4), but not TLR2, polymorphisms modify the risk of tonsillar disease due to Streptococcus pyogenes and Haemophilus influenzae. Clin Vaccine Immunol 18:217-222.
128. Liao WL, Chen RH, Lin HJ, Liu YH, Chen WC, Tsai Y, Wan L, Tsai FJ. 2010. Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males. BMC Med Genet 11:154.
129. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, IngallsRR,Radolf JD,GolenbockDT. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products J Biol Chem 274:33419-33425.
130. Lin SC, Lo YC, Wu H. 2010. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465:885-890.
131. Liu B, Yang Y, Qiu Z, Staron M, Hong F, Li Y, Wu S, Li Y, Hao B, Bona R, Han D, Li Z. 2010. Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone. Nat Commun 1:79.
132. Lorenz E, Hallman M, Marttila R, Haataja R, Schwartz DA. 2002a. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 52:373-376.
133. Lorenz E, Mira JP, Frees KL, Schwartz DA. 2002b. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162:1028-1032.
134. Lundberg A, Wikberg LA, Ilonen J, Vaarala O, Bö ttcher MF. 2008. Lipopolysaccharide-induced immune responses in relation to the TLR4(Asp299Gly) gene polymorphism. Clin Vaccine Immunol 15:1878-1883.
135. Mandal RK, George GP, Mittal RD. 2012. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population. Mol Biol Rep 39:7263-7269.
136. Mantegazza AR, Guttentag SH, El-Benna J, Sasai M, Iwasaki A, Shen H, Laufer TM, Marks MS. 2012. Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4( + ) T cells. Immunity 36:782-794.
137. Mantovani A, Allavena P, Sica A, Balkwill F. 2008. Cancer-related inflammation Nature 454:436-444.
138. McGettrick AF, O'Neill LA. 2010. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr Opin Immunol 22:20-27.
139. McWhirter SM, Fitzgerald KA, Rosains J, Rowe DC, Golenbock DT, Maniatis T. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci USA 101:233-238.
140. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. 1999 Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis J Immunol 163:3920-3927.
141. Medhi S, Deka M, Deka P, Swargiary SS, Hazam RK, Sharma MP, Gumma PK, Asim M, Kar P. 2011. Promoter region polymorphism & expression profile of toll like receptor-3 (TLR-3) gene in chronic hepatitis C virus (HCV) patients from India. Indian J Med Res 134:200-207.
142. Medzhitov R. 2007. TLR-mediated innate immune recognition. Semin Immunol 19:1-2.
143. Medzhitov R. 2009. Damage control in host-pathogen interactions. Proc Natl Acad Sci USA 106:15525-15526.
144. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397.
145. Michel O, LeVan TD, Stern D, Dentener M, Thorn J, Gnat D, Beijer ML, Cochaux P, Holt PG, Martinez FD, Rylander R. 2003. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings J Allergy Clin Immunol 112:923-929.
146. Miedema KG, Tissing WJ, Te Poele EM, Kamps WA, Alizadeh BZ, Kerkhof M, de Jongste JC, Smit HA, de Pagter AP, Bierings M, Boezen HM, Postma DS, de Bont ES, Koppelman GH. 2012. Polymorphisms in the TLR6 gene associated with the inverse association between childhood acute lymphoblastic leukemia and atopic disease. Leukemia 26:1203-1210.
147. Minmin S, Xiaoqian X, Hao C, Baiyong S, Xiaxing D, Junjie X, Xi Z, Jianquan Z, Songyao J. 2011. Single nucleotide polymorphisms of Toll-like receptor 4 decrease the risk of development of hepatocellular carcinoma. PLoS One 6:e19466.
148. Minnicozzi M, Sawyer RT, Fenton MJ. 2011. Innate immunity in allergic disease. Immunol Rev 242:106-127.
149. Møller-Larsen S, Nyegaard M, Haagerup A, Vestbo J, Kruse TA, Børglum AD. 2008. Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax 63:1064-1069.
150. Motsinger-Reif AA, Antas PR, Oki NO, Levy S, Holland SM, Sterling TR. 2010. Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. BMC Med Genet 11:37
151. Moynagh PN. 2009. The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling. Trends Immunol 30:33-42.
152. Mrabet-Dahbi S, Dalpke AH, Niebuhr M, Frey M, Draing C, Brand S, Heeg K, Werfel T, Renz H. 2008. The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol 121:1013-1019.
153. Nadigel J, Préfontaine D, Baglole CJ, Maltais F, Bourbeau J, Eidelman DH, Hamid Q. 2011. Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8( + ) T cells in chronic obstructive pulmonary disease. Respir Res 12:149.
154. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M, Miyake K. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3:667-672.
155. Najmi N, Kaur G, Sharma SK, Mehra NK. 2010. Human Toll-like receptor 4 polymorphisms TLR4 Asp299Gly and Thr399Ile influence susceptibility and severity of pulmonary tuberculosis in the Asian Indian population. Tissue Antigens 76: 102-109.
156. Nakada TA, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, Watanabe E, Abe R, Hatano M, Tokuhisa T. 2005. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients. J Surg Res 129:322-328.
157. Nakamura K, Miyazato A, Xiao G, Hatta M, Inden K, Aoyagi T, Shiratori K, Takeda K, Akira S, Saijo S, Iwakura Y, Adachi Y, Ohno N, Suzuki K, Fujita J, Kaku M, Kawakami K. 2008. Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway. J Immunol 180:4067-4074.
158. Netea MG, Wijmenga C, O'Neill LA. 2012. Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol 13:535-542.
159. Neumann D, Kollewe C, Resch K, Martin MU. 2007. The death domain of IRAK-1: an oligomerization domain mediating interactions with MyD88, Tollip, IRAK-1, and IRAK-4. Biochem Biophys Res Commun 354:1089-1094.
160. Newport MJ, Allen A, Awomoyi AA, Dunstan SJ, McKinney E, Marchant A, Sirugo G. 2004. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia Tuberculosis 84:347-352.
161. Niebuhr M, Langnickel J, Draing C, Renz H, Kapp A, Werfel T. 2008. Dysregulation of toll-like receptor-2 (TLR-2)-induced effects in monocytes from patients with atopic dermatitis: impact of the TLR-2 R753Q polymorphism. Allergy 63: 728-734.
162. Nischalke HD, Berger C, Aldenhoff K, Thyssen L, Gentemann M, Grü nhage F, Lammert F, Nattermann J, Sauerbruch T, Spengler U, Appenrodt B. 2011. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol 55:1010-1016.
163. Nischalke HD, Coenen M, Berger C, Aldenhoff K, Mü ller T, Berg T, Krämer B, Kö rner C, Odenthal M, Schulze F, Grü nhage F, Nattermann J, Sauerbruch T, Spengler U. 2012. The toll-like receptor 2 (TLR2)-196 to-174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C. Int J Cancer 130: 1470-1475.
164. Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki M, Arinami T. 2004. An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 34:177-183.
165. O'Neill LA. 2008. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 29:12-20.
166. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G. 2006. Critical role of TRAF3 in the Tolllike receptor-dependent and-independent antiviral response. Nature 439:208-211.
167. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I, Coskun M, Cilli A, Yegin O. 2004. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 23:219-223.
168. Oh DY, Baumann K, Hamouda O, Eckert JK, Neumann K, Kü-cherer C, Bartmeyer B, Poggensee G, Oh N, Pruss A, Jessen H, Schumann RR. 2009. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS 23:297-307.
169. Oldenburg M, Krü ger A, Ferstl R, Kaufmann A, Nees G, Sigmund A, Bathke B, Lauterbach H, Suter M, Dreher S, Koedel U, Akira S, Kawai T, Buer J, Wagner H, Bauer S, Hochrein H, Kirschning CJ. 2012. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 337:1111-1115.
170. Ordureau A, Smith H, Windheim M, Peggie M, Carrick E, Morrice N, Cohen P. 2008. The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem J 409:43-52.
171. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97:13766-13771.
172. Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Lal P, Mittal RD. 2011. Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility. Mol Biol Rep 38:4715-4721.
173. Pandey S, Mittal RD, Srivastava M, Srivastava K, Singh S, Srivastava S, Mittal B. 2009. Impact of Toll-like receptors [TLR] 2 (-196 to-174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecol Oncol 114:501-505.
174. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. 2009. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:1191-1195.
175. Pasare C, Medzhitov R. 2005. Control of B-cell responses by Tolllike receptors. Nature 438:364-368.
176. Paulus SC, Hirschfeld AF, Victor RE, Brunstein J, Thomas E, Turvey SE. 2007. Common human Toll-like receptor 4 polymorphisms-role in susceptibility to respiratory syncytial virus infection and functional immunological relevance. Clin Immunol 123:252-257.
177. Pegu A, Qin S, Fallert Junecko BA, Nisato RE, Pepper MS, Reinhart TA. 2008. Human lymphatic endothelial cells express multiple functional TLRs. J Immunol 180:3399-3405.
178. Pietschmann K, Beetz S, Welte S, Martens I, Gruen J, Oberg HH, Wesch D, Kabelitz D. 2009. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes. Scand J Immunol 70:245-255.
179. Pino-Yanes M, Corrales A, Casula M, Blanco J, Muriel A, Espinosa E, Garc?́a-Bello M, Torres A, Ferrer M, Zavala E, Villar J, Flores C; GRECIA and GEN-SEP Groups. 2010. Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsis. PLoS One 5:e13759.
180. Plantinga TS, Johnson MD, Scott WK, van de Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, Oosting M, Joosten LA, van der Meer JW, van Dissel JT, Walsh TJ, Perfect JR, Kullberg BJ, Netea MG. 2012. Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. J Infect Dis 205:934-943.
181. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088.
182. Prohinar P, Rallabhandi P, Weiss JP, Gioannini TL. 2010. Expression of functional D299G.T399I polymorphic variant of TLR4 depends more on coexpression of MD-2 than does wildtype TLR4. J. Immunol 184(8):4362-4367.
183. Pulido I, Leal M, Genebat M, Pacheco YM, Sáez ME, Soriano-Sarabia N. 2010. The TLR4 ASP299GLY polymorphism is a risk factor for active tuberculosis in Caucasian HIV-infected patients. Curr HIV Res 8:253-258.
184. Quevedo-Diaz MA, Song C, Xiong Y, Chen H, Wahl LM, Radulovic S, Medvedev AE. 2010. Involvement of TLR2 and TLR4 in cell responses to Rickettsia akari J Leukoc Biol 88:675-685.
185. Radstake TR, Franke B, Hanssen S, Netea MG, Welsing P, Barrera P, Joosten LA, van Riel PL, van den Berg WB. 2004. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 50:999-1001.
186. Ragnarsdottir B, Jonsson K, Urbano A, Gronberg-Hernandez J, Lutay N, Tammi M, Gustafsson M, Lundstedt AC, Leijonhufvud I, Karpman D, Wullt B, Truedsson L, Jodal U, Andersson B, Svanborg C. 2010. Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection PLoS One 5:e10734.
187. Rakoff-Nahoum S, Medzhitov R. 2009. Toll-like receptors and cancer. Nat Rev Cancer 9:57-63.
188. Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M, Hemming VG, Blanco JC, Segal DM, Vogel SN. 2006. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol 177:322-332.
189. Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, Hornung V, Vogel SN, Szomolanyi-Tsuda E, Fitzgerald KA. 2010. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 11:395-402.
190. Reijmerink NE, Bottema RW, Kerkhof M, Gerritsen J, Stelma FF, Thijs C, van Schayck CP, Smit HA, Brunekreef B, Koppelman GH, Postma DS. 2010. TLR-related pathway analysis: novel gene-gene interactions in the development of asthma and atopy. Allergy 65:199-207.
191. Saçkesen C, Karaaslan C, Keskin O, Tokol N, Tahan F, Civelek E, Soyer OU, Adalioglu G, Tuncer A, Birben E, Oner C, Kalayci O. 2005. The effect of polymorphisms at the CD14 promoter and the TLR4 gene on asthma phenotypes in Turkish children with asthma. Allergy 60:1485-1492.
192. Salpietro C, Rigoli L, Miraglia Del Giudice M, Cuppari C, Di Bella C, Salpietro A, Maiello N, La Rosa, M, Marseglia GL, Leonardi S, Briuglia S, Ciprandi G. 2011 TLR2 and TLR4 gene polymorphisms and atopic dermatitis in Italian children: a multicenter study. Int J Immunopathol Pharmacol 24:33-40.
193. Sampath V, Garland JS, Le M, Patel AL, Konduri GG, Cohen JD, Simpson PM, Hines RN. 2012. A TLR5 (g.1174C > T) variant that encodes a stop codon (R392 • ) is associated with bronchopulmonary dysplasia. Pediatr Pulmonol 47:460-468.
194. Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, Akira S. 2003. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 171:4304-4310.
195. Schenten D, Medzhitov R. 2011. The control of adaptive immune responses by the innate immune system. Adv Immunol 109:87-124.
196. Schott E, Witt H, Neumann K, Bergk A, Halangk J, Weich V, Mü ller T, Puhl G, Wiedenmann B, Berg T. 2008. Association of TLR7 single nucleotide polymorphisms with chronic HCVinfection and response to interferon-a-based therapy. J Viral Hepat 15:71-78.
197. Schott E, Witt H, Neumann K, Taube S, Oh DY, Schreier E, Vierich S, Puhl G, Bergk A, Halangk J, Weich V, Wiedenmann B, Berg T. 2007. A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. J Hepatol 47:203-211.
198. Schuring RP, Hamann L, Faber WR, Pahan D, Richardus JH, Schumann RR, Oskam L. 2009. Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J Infect Dis 199:1816-1819.
199. Senthilselvan A, Dosman JA, Chénard L, Burch LH, Predicala BZ, Sorowski R, Schneberger D, Hurst T, Kirychuk S, Gerdts V, Cormier Y, Rennie DC, Schwartz DA. 2009. Toll-like receptor 4 variants reduce airway response in human subjects at high endotoxin levels in a swine facility. J Allergy Clin Immunol 123:1034-1040.
200. Senthilselvan A, Rennie D, Chénard L, Burch LH, Babiuk L, Schwartz DA, Dosman JA. 2008. Association of polymorphisms of toll-like receptor 4 with a reduced prevalence of hay fever and atopy. Ann Allergy Asthma Immunol 100:463-468.
201. Seong SY, Matzinger P. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4:469-478.
202. Shalhub S, Junker CE, Imahara SD, Mindrinos MN, Dissanaike S, O'Keefe GE. 2009. Variation in the TLR4 gene influences the risk of organ failure and shock posttrauma: a cohort study. J Trauma 66:115-123.
203. Shen X, Shi R, Zhang H, Li K, Zhao Y, Zhang R. 2010. The Tolllike receptor 4 D299G and T399I polymorphisms are associated with Crohn's disease and ulcerative colitis: a meta-analysis. Digestion 81:69-77.
204. Shi Z, Cai Z, Sanchez A, Zhang T, Wen S, Wang J, Yang J, Fu S, Zhang D. 2011. A novel Toll-like receptor that recognizes vesicular stomatitis virus. J Biol Chem 286:4517-4524.
205. Sironi M, Biasin M, Cagliani R, Forni D, De Luca M, Saulle I, Lo Caputo S, Mazzotta F, Mac?́as J, Pineda JA, Caruz A, Clerici M. 2012. A common polymorphism in TLR3 confers natural resistance to HIV-1 infection. J Immunol 188:818-823.
206. Sivula J, Cordova ZM, Tuimala J, Jaatinen T, Partanen J, Volin L, Turpeinen H. 2012. Toll-like receptor gene polymorphisms confer susceptibility to graft-versus-host disease in allogenic hematopoietic stem cell transplantation. Scand J Immunol 76:336-341.
207. Slattery ML, Herrick JS, Bondurant KL, Wolff RK. 2012. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Int J Cancer 130:2974-2980.
208. Smit LA, Bongers SI, Ruven HJ, Rijkers GT, Wouters IM, Heederik D, Omland ∅, Sigsgaard T. 2007. Atopy and new-onset asthma in young Danish farmers and CD14, TLR2, and TLR4 genetic polymorphisms: a nested case-control study. Clin Exp Allergy 37:1602-1608.
209. Smit LA, Siroux V, Bouzigon E, Oryszczyn MP, Lathrop M, Demenais F, Kauffmann F; Epidemiological Study on the Genetics and Environment of Asthma, Bronchial Hyperresponsiveness, and Atopy (EGEA) Cooperative Group. 2009. CD14 and toll-like receptor gene polymorphisms, country living, and asthma in adults. Am J Respir Crit Care Med 179:363-368.
210. Soylu A, Atesx H, Cingöz S, Tü rkmen M, Demir BK, Tunca M, Sak?zl? M, Cirit M, Ersoy R, Ulgenalp A, Kavukçu S. 2011. TLR polymorphisms in FMF: association of TLR-2 (Arg753Gln) and TLR-4 (Asp299Gly, Thre399Ile) polymorphisms and myeloid cell TLR-2 and TLR-4 expression with the development of secondary amyloidosis in FMF. Inflammation 34:379-387.
211. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, Moore KJ. 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11:155-161.
212. Svensson A, Tunbäck P, Nordström I, Padyukov L, Eriksson K. 2012. Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection. J Gen Virol 93:1717-1724.
213. Tada H, Nemoto E, Shimauchi H, Watanabe T, Mikami T, Matsumoto T, Ohno N, Tamura H, Shibata K, Akashi S, Miyake K, Sugawara S, Takada H. 2002. Saccharomyces cerevisiae-and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14-and Toll-like receptor 4-dependent manner. Microbiol Immunol 46:503-512.
214. Takahashi K, Shibata T, Akashi-Takamura S, Kiyokawa T, Wakabayashi Y, Tanimura N, Kobayashi T, Matsumoto F, Fukui R, Kouro T, Nagai Y, Takatsu K, Saitoh S, Miyake K. 2007. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J Exp Med 204:2963-2976.
215. Takahashi M, Chen Z, Watanabe K, Kobayashi H, Nakajima T, Kimura A, Izumi Y. 2011. Toll-like receptor 2 gene polymorphisms associated with aggressive periodontitis in Japanese. Open Dent J 5:190-194.
216. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501-505.
217. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S. 2002. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169:10-14.
218. Tal G, Mandelberg A, Dalal I, Cesar K, Somekh E, Tal A, Oron A, Itskovich S, Ballin A, Houri S, Beigelman A, Lider O, Rechavi G, Amariglio N. 2004. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 189:2057-2063.
219. Taylor BD, Darville T, Ferrell RE, Kammerer CM, Ness RB, Haggerty CL. 2012. Variants in toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease. J Infect Dis 205:603-609.
220. Theodoropoulos GE, Saridakis V, Karantanos T, Michalopoulos NV, Zagouri F, Kontogianni P, Lymperi M, Gazouli M, Zografos GC. 2012. Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development. Breast 21:534-538.
221. Tsuchiya K, Hara H, Kawamura I, Nomura T, Yamamoto T, Daim S, Dewamitta SR, Shen Y, Fang R, Mitsuyama M. 2010. Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes. J Immunol 185:1186-1195.
222. Tulic MK, Hurrelbrink RJ, Prele CM, Laing IA, Upham JW, Le Souef P, Sly PD, Holt PG. 2007a. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol 179:132-140.
223. Tulic MK, Hurrelbrink RJ, Prêle CM, Laing IA, Upham JW, Le Souef P, Sly PD, Holt PG. 2007b. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol 179:132-140.
224. Uehara A, Fujimoto Y, Fukase K, Takada H. 2007. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol 44:3100-3111.
225. Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F, Matsuda M, Coban C, Ishii KJ, Kawai T, Takeuchi O, Akira S. 2005. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7-and TLR9-mediated interferon-{alpha} induction. J Exp Med 201:915-923.
226. Ueta M, Sotozono C, Inatomi T, Kojima K, Tashiro K, Hamuro J, Kinoshita S. 2007. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Ophthalmol 91:962-965.
227. Ueta M, Tokunaga K, Sotozono C, Sawai H, Tamiya G, Inatomi T, Kinoshita S. 2012. HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications. PLoS One 7:e43650.
228. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, Fitzgerald KA, Paludan SR, Bowie AG. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11:997-1004.
229. Van der Graaf CA, Netea MG, Morré SA, Den Heijer M, Verweij PE, Van der Meer JW, Kullberg BJ. 2006. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 17:29-34.
230. Verstraelen H, Verhelst R, Nuytinck L, Roelens K, De Meester E, De Vos D, Van Thielen M, Rossau R, Delva W, De Backer E, Vaneechoutte M, Temmerman M. 2009. Gene polymorphisms of Toll-like and related recognition receptors in relation to the vaginal carriage of Gardnerella vaginalis and Atopobium vaginae. J Reprod Immunol 79:163-173.
231. Vogel SN, Awomoyi AA, Rallabhandi P, Medvedev AE. 2005. Mutations in TLR4 signaling that lead to increased susceptibility to infection in humans: an overview. J Endotoxin Res 11:333-339.
232. Vogel SN, Fitzgerald KA, Fenton MJ. 2003. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol Interv 3:466-477.
233. Vogel SN, Johnson D, Perera PY, Medvedev A, Larivière L, Qureshi ST, Malo D. 1999. Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. J Immunol 162:5666-5670.
234. Vuononvirta J, Toivonen L, Gröndahl-Yli-Hannuksela K, Barkoff AM, Lindholm L, Mertsola J, Peltola V, He Q. 2011. Nasopharyngeal bacterial colonization and gene polymorphisms of mannose-binding lectin and toll-like receptors 2 and 4 in infants. PLoS One 6:e26198.
235. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346-351.
236. Wang CH, Eng HL, Lin KH, Chang CH, Hsieh CA, Lin YL, Lin TM. 2011. TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. PLoS One 6:e26235.
237. Warren SE, Armstrong A, Hamilton MK, Mao DP, Leaf IA, Miao EA, Aderem A. 2010. Cutting edge: Cytosolic bacterial DNA activates the inflammasome via Aim2. J Immunol 185: 818-821.
238. Werner M, Topp R, Wimmer K, Richter K, Bischof W, Wjst M, Heinrich J. 2003. TLR4 gene variants modify endotoxin effects on asthma. J Allergy Clin Immunol 112:323-330.
239. Wu S, Hong F, Gewirth D, Guo B, Liu B, Li Z. 2012. The molecular chaperone gp96/GRP94 interacts with Toll-like receptors and integrins via its C-terminal hydrophobic domain. J Biol Chem 287:6735-6742.
240. Wurfel MM, Gordon AC, Holden TD, Radella F, Strout J, Kajikawa O, Ruzinski JT, Rona G, Black RA, Stratton S, Jarvik GP, Hajjar AM, Nickerson DA, Rieder M, Sevransky J, Maloney JP, Moss M, Martin G, Shanholtz C, Garcia JG, Gao L, Brower R, Barnes KC, Walley KR, Russell JA, Martin TR. 2008. Tolllike receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 178:710-720.
241. Xiong Y, Qiu F, Piao W, Song C, Wahl LM, Medvedev AE. 2011. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression. J Biol Chem 286:7905-7916.
242. Xiong Y, Song C, Snyder GA, Sundberg EJ, Medvedev AE. 2012. Arg753Gln polymorphism inhibits Toll-like Receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6 and myeloid differentiation primary response protein 88 recruitment. J Biol Chem 287:38327-38337.
243. Xu Y, Tao X, Shen B, Horng T, Medzhitov R, Manley JL, Tong L. 2000. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408:111-115.
244. Xue Y, Jin L, Li AZ, Wang HJ, Li M, Zhang YX, Wang Y, Li JC. 2010a. Microsatellite polymorphisms in intron 2 of the toll-like receptor 2 gene and their association with susceptibility to pulmonary tuberculosis in Han Chinese. Clin Chem Lab Med 48:785-789.
245. Xue Y, Zhao ZQ, Wang HJ, Jin L, Liu CP, Wang Y, Li JC. 2010b. Toll-like receptors 2 and 4 gene polymorphisms in a southeastern Chinese population with tuberculosis. Int J Immunogenet 37:135-138.
246. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640-643.
247. Yang IA, Barton SJ, Rorke S, Cakebread JA, Keith TP, Clough JB, Holgate ST, Holloway JW. 2004. Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun 5:41-45.
248. Yang P, An H, Liu X, Wen M, Zheng Y, Rui Y, Cao X. 2010. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol 11:487-494.
249. Yang Y, Liu B, Dai J, Srivastava PK, Zammit DJ, Lefrançois L, Li Z. 2007. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 26:215-226.
250. Yang ZH, Dai Q, Gu YJ, Guo QX, Gong L. 2012. Cytokine and chemokine modification by Toll-like receptor polymorphisms is associated with nasopharyngeal carcinoma. Cancer Sci 103:653-658.
251. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, Sher A. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308:1626-1629.
252. Yim JJ, Lee HW, Lee HS, Kim YW, Han SK, Shim YS, Holland SM. 2006. The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes Immun 7:150-155.
253. Zaki HY, Leung KH, Yiu WC, Gasmelseed N, Elwali NE, Yip SP. 2012. Common polymorphisms in TLR4 gene associated with susceptibility to pulmonary tuberculosis in the Sudanese. Int J Tuberc Lung Dis 16:934-940.
254. Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC. 2011. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147:868-880.
255. Zeng HM, Pan KF, Zhang Y, Zhang L, Ma JL, Zhou T, Su HJ, Li WQ, Li JY, Gerhard M, Classen M, You WC. 2011. Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population. Cancer Epidemiol Biomarkers Prev 20:2594-2602.
256. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S. 2004. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522-1526.
257. Zhang Q, Qian FH, Zhou LF, Wei GZ, Jin GF, Bai JL, Yin KS. 2011. Polymorphisms in toll-like receptor 4 gene are associated with asthma severity but not susceptibility in a Chinese Han population. J Investig Allergol Clin Immunol 21:370-377.
258. Zheng SL, Augustsson-Bä lter K, Chang B, Hedelin M, Li L, Adami HO, Bensen J, Li G, Johnasson JE, Turner AR, Adams TS, Meyers DA, Isaacs WB, Xu J, Grönberg H. 2004. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res 64:2918-2922.
259. Zhou S, Kurt-Jones EA, Mandell L, Cerny A, Chan M, Golenbock DT, Finberg RW. 2005. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur J Immunol 35:822-830.